Brief: Ani Pharmaceuticals Expands Rare Disease Business Through Acquisition Of Alimera Sciences

ANI Pharmaceuticals

24/06/2024 11:56

June 24 (Reuters) - Alimera Sciences Inc  ALIM.O :
    * ANI PHARMACEUTICALS TO FURTHER EXPAND RARE DISEASE
BUSINESS
THROUGH ACQUISITION OF ALIMERA SCIENCES
    * ALIMERA SCIENCES INC: PROPOSED DEAL FOR $5.50 PER SHARE IN
CASH
    * ALIMERA SCIENCES: DEAL TO DRIVE HIGH SINGLE DIGIT TO LOW
DOUBLE
DIGIT ACCRETION IN ADJUSTED NON-GAAP EPS IN 2025
    * ALIMERA SCIENCES: ANI INTENDS TO FINANCE DEAL USING
COMBINATION
OF CASH ON HAND & DEBT FINANCING
    * ALIMERA SCIENCES: INVESTORS TO BE ENTITLED TO CVR FOR UP
TO
$0.50/SHARE, BASED ON ACHIEVING NET REVENUE IN EXCESS OF
SPECIFIED THRESHOLDS IN 2026, 2027

Source text for Eikon:  ID:nGNX8PtTZ6 
Further company coverage:  ALIM.O 

 ((Reuters.Briefs@thomsonreuters.com;))